Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage

Neuroscience

Volumn 269, Issue , 2014, Pages 134-142

  Yamazaki, Y ^a   Harada, S ^a   Tokuyama, S ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Glucose transporter; Hyperglycemia; Neuroprotection; SGLT

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; GLUCOSE; SMALL INTERFERING RNA; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 3; UNCLASSIFIED DRUG; CHOLINESTERASE INHIBITOR; GLUCOSE BLOOD LEVEL; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE; SLC5A1 PROTEIN, MOUSE; SLC5A4B PROTEIN, MOUSE; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DIET RESTRICTION; DISEASE COURSE; DISEASE EXACERBATION; ENZYME LOCALIZATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHALAMUS; IMMUNOFLUORESCENCE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NERVE CELL STIMULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; ASTROCYTE; DISEASE MODEL; DRUG EFFECTS; GENE SILENCING; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; NERVE CELL; OUTBRED STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; ANIMALS, OUTBRED STRAINS; ASTROCYTES; BLOOD GLUCOSE; BRAIN ISCHEMIA; CHOLINESTERASE INHIBITORS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HIPPOCAMPUS; HYPOTHALAMUS; INDANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; NEURONS; PIPERIDINES; RNA, SMALL INTERFERING; SODIUM-GLUCOSE TRANSPORT PROTEINS; SODIUM-GLUCOSE TRANSPORTER 1; STRESS, PHYSIOLOGICAL;

EID: 84898849033     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.03.046     Document Type: Article

References (31)

1. Balteau M., Tajeddine N., de Meester C., Ginion A., Des Rosiers C., Brady N.R., Sommereyns C., Horman S., Vanoverschelde J.L., Gailly P., Hue L., Bertrand L., Beauloye C. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovasc Res 2011, 92:237-246.
2. Benchoua A., Guégan C., Couriaud C., Hosseini H., Sampaïo N., Morin D., Onténiente B. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci 2001, 21:7127-7134.
3. Bianchi L., Díez-Sampedro A. A single amino acid change converts the sugar sensor SGLT3 into a sugar transporter. PLoS One 2010, 5:e10241.
4. Diez-Sampedro A., Hirayama B.A., Osswald C., Gorboulev V., Baumgarten K., Volk C., Wright E.M., Koepsell H. Proc Natl Acad Sci U S A 2003, 100:11753-11758.
5. Fuentes B., Castillo J., San Jose B., Leira R., Serena J., Vivancos J., Davalos A., Nunez A.G., Egido J., Diez-Tejedor E. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in acute stroke (GLIAS) study. Stroke 2009, 40:562-568.
6. Fujiki M., Kobayashi H., Uchida S., Inoue R., Ishii K. Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res 2005, 1043:236-241.
7. Gentile N.T., Seftchick M.W., Huynh T., Kruus L.K., Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006, 13:174-180.
8. Haley T.J., McCormik W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957, 12:12-15.
9. Harada S., Fujita W.H., Shichi K., Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 2009, 1279:174-181.
10. Harada S., Fujita-Hamabe W., Tokuyama S. Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J Pharmacol Sci 2011, 115:155-163.
11. Harada S., Yamazaki Y., Tokuyama S. Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor. J Pharmacol Exp Ther 2012, 344:276-285.
12. He H., Kang R., Zhao Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS One 2013, 8:e81305.
13. Hotta H., Uchida S., Kagitani F. Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex. Jpn J Physiol 2002, 52:383-393.
14. Kim J.H., Kim E.J., Seo B.K., Lee S., Lee S., Jung S.Y., Lee M.H., Kim A.R., Park H.J., Shin M.S., Choi S.M. Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial. Trials 2013, 14:254.
15. Lee J.H., Park S.Y., Shin Y.W., Kim C.D., Lee W.S., Hong K.W. Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Res 2007, 1185:246-255.
16. Matsuoka T., Nishizaki T., Kisby G.E. Na+-dependent and phlorizin-inhibitable transport of glucose and cycasin in brain endothelial cells. J Neurochem 1998, 70:772-777.
17. Matz K., Keresztes K., Tatschl C., Nowotny M., Dachenhausenm A., Brainin M., Tuomilehto J. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care 2006, 29:792-797.
18. Nakai M., Akino H., Kaneda T., Matsuta Y., Shiyama R., Tanase K., Ito H., Aoki Y., Oyama N., Miwa Y., Yokoyama O. Acetylcholinesterase inhibitor acting on the brain improves detrusor overactivity caused by cerebral infarction in rats. Neuroscience 2006, 142:475-480.
19. O'Malley D., Reimann F., Simpson A.K., Gribble F.M. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 2006, 55:3381-3386.
20. Poppe R., Karbach U., Gambaryan S., Wiesinger H., Lutzenburg M., Kraemer M., Witte O.W., Koepsell H. Expression of the Na+-d-glucose cotransporter SGLT1 in neurons. J Neurochem 1997, 69:84-94.
21. Rezazadeh H., Hoseini Kahnuee M., Roohbakhsh A., Shamsizadeh A., Rahmani M.R., Bidaki R., Amin F., Kamali B., Bakhshi H., Allahtavakoli M. Neuroprotective consequences of postconditioning on embolic model of cerebral ischemia in rat. Iran J Basic Med Sci 2013, 16:144-149.
22. Rizk N.N., Rafols J.A., Dunbar J.C. Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res 2006, 1096:204-212.
23. Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circ J 2012, 76:1066-1073.
24. Scheepers A., Joost H.G., Schürmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J Parenter Enteral Nutr 2004, 28:364-371.
25. Shichi K., Fujita-Hamabe W., Harada S., Mizoguchi H., Yamada K., Nabeshima T., Tokuyama S. Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. J Pharmacol Exp Ther 2011, 338:701-710.
26. Vemula S., Roder K.E., Yang T., Bhat G.J., Thekkumkara T.J., Abbruscato T.J. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther 2009, 328:487-495.
27. Voss A.A., Díez-Sampedro A., Hirayama B.A., Loo D.D., Wright E.M. Imino sugars are potent agonists of the human glucose sensor SGLT3. Mol Pharmacol 2007, 71:628-634.
28. Winters A., Taylor J.C., Ren M., Ma R., Liu R., Yang S.H. Transient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke model. Transl Stroke Res 2012, 3:279-285.
29. Wright E.M., Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch 2004, 447:510-518.
30. Yamazaki Y., Harada S., Tokuyama S. Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res 2012, 1489:113-120.
31. Yu A.S., Hirayama B.A., Timbol G., Liu J., Diez-Sampedro A., Kepe V., Satyamurthy N., Huang S.C., Wright E.M., Barrio J.R. Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol 2011, 304:240-247.